Hyperproinsulinemia in Type II Diabetes

Cohen, Robert M; Nathan, David M; Clements, Rex S

doi:10.2337/diacare.15.5.723

Robert M Cohen, MD;

Robert M Cohen, MD

Department of Internal Medicine, University of Cincinnati College of Medicine

Cincinnati, Ohio

;

Department of Medicine, Massachusetts General Hospital and Harvard Medical School

Boston, Massachusetts

; and the

Department of Medicine, University of Pennsylvania School of Medicine

Phiiadelphia, Pennsylvania

Search for other works by this author on:

This Site

PubMed

Google Scholar

David M Nathan, MD;

David M Nathan, MD

Department of Internal Medicine, University of Cincinnati College of Medicine

Cincinnati, Ohio

;

Department of Medicine, Massachusetts General Hospital and Harvard Medical School

Boston, Massachusetts

; and the

Department of Medicine, University of Pennsylvania School of Medicine

Phiiadelphia, Pennsylvania

Search for other works by this author on:

This Site

PubMed

Google Scholar

Rex S Clements, Jr, MD

Department of Internal Medicine, University of Cincinnati College of Medicine

Cincinnati, Ohio

;

Department of Medicine, Massachusetts General Hospital and Harvard Medical School

Boston, Massachusetts

; and the

Department of Medicine, University of Pennsylvania School of Medicine

Phiiadelphia, Pennsylvania

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence and reprint requests to Rex S. Clements, Jr, MD, Novo Nordisk Pharmaceuticals Inc., 100 Overlook Center, Princeton, NJ 08540.

Hyperproinsulinemia in Type II Diabetes

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Hyperproinsulinemia in Type II Diabetes

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only